SBIR/STTR Research Award

Enhanced MDx: a computational model to optimize pre-analytical pathogen isolation from whole blood

Award identifier 975a22d8c3316a044b614301f600c6c00b4215166d1b978e5577542fbf25cf2fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,986,695

Program and phase

STTR · Phase II

Award year

2022

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Redbud Labs, Inc.
Proposal award date
2022-06-21
Contract end date
2024-05-31
UEI
KJGXVMFV9U14
Solicitation number
PA21-262
Topic code
400

Research abstract

ABSTRACTMicroscale simulations have been applied to a number of complex microfluidic systems and biological applications, but existing methods are limited in the scale and scope of problems that are addressable. Thermodynamically constrained averaging theory (TCAT) is an established approach that can be used to formulate customized macroscale models that are consistent with microscale physics and thermodynamics. TCAT modeling frameworks have been developed, evaluated, and validated for a wide range of applications involving fluid and solid phases, and in Phase I of this project, Redbud Labs’ actuatable post technology enabling rapid target isolation and concentration was successfully modeled by the Griffith and Miller Labs at the University of North Carolina at Chapel Hill at both the micro and macroscale. This will enable future in silico optimization of these microfluidic systems for use in Point of Care Diagnostic (POC Dx)In this Phase II study, we will expand upon the models developed in Phase I to include scenarios relevant to a broad group of molecular diagnostics, including those where off target species are plentiful and target species are exceedingly rare. In addition, Phase II models will include relevant biological matrices such as whole blood, plasma, and saliva. The developed computational model will then be used to optimize high-impact purification/diagnostic assays for HIV, SARS-CoV-2, cancer detection (liquid biopsy), and sepsis. Finally, the optimized components will be ported to Redbud Labs’ existing sample prep platform, NAxtract, and made available for research use only applications.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

25 SBIR/STTR records share this UEI (2012–2024). Reported award amounts total $25,418,736. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.